Vineti

Cell & Gene Therapy Software

Company website

Foundation year

2016

Pre-IPO

Current offer

Placement price Available after authorization

Minimum investment Available after authorization

Available volume Available after authorization

Make a request

About

Total funding amount:

115.3M
______________________________________________

Vineti is a commercial cloud platform that expands patient access to life-saving cell and gene therapies. It is a software solution for managing and scaling personalized therapeutic innovations. It helps to address key challenges faced by patients, healthcare professionals, pharmaceutical companies, and regulatory agencies in delivering and commercializing personalized medicine.
__________________________________________

Number of employees:

51-100
___________________________________________

Headquarters location:
San Francisco, California, USA.

Investors

Canaan Partners

Instacart, Turo, The RealReal, Lending Club, Berkshire Grey, Kustomer, ON24, ShopKeep, Apartment List, ScaleFactor

Cardinal Health

Vineti

Casdin Capital

23andMe, ORIC Pharmaceuticals, Codiak Biosciences, Vineti

dRx Capital

Vineti

HIVE Ventures

ServiceTitan, Vineti

Kite Pharma

Vineti

LifeForce Capital

HeartFlow, One Medical, Clover Health, Vineti, Verge Genomics

Section 32

Metromile, Celularity, Kobalt, Dialpad, Vineti

Threshold

Talkdesk, CircleCI, Yellowbrick Data, BetterUp, SugarCRM, Vineti, Doximity, Forward Networks, Verge Genomics